| Yelena Kantarzhi, APNC | |
|
434 Palisade Ave, Cliffside Park, NJ 07010-2839 | |
| (201) 943-4884 | |
| Not Available |
| Full Name | Yelena Kantarzhi |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Women's Health |
| Location | 434 Palisade Ave, Cliffside Park, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366637654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SW0102X | Clinical Nurse Specialist - Women's Health | 26NN09454500 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Yelena Kantarzhi, APNC 434 Palisade Ave, Cliffside Park, NJ 07010-2839 Ph: (201) 943-4884 | Yelena Kantarzhi, APNC 434 Palisade Ave, Cliffside Park, NJ 07010-2839 Ph: (201) 943-4884 |
News Archive
A team of Utahns is collaborating on a stem cell therapy to fight amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
CIGNA International, a world leader in expatriate benefits, has added 47,000 health care facilities to its network in Africa as part of its launch of CIGNALinks® Africa in South Africa, Kenya, Tanzania, and Morocco.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company, today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR (SABER-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
Henry Ford Health System today announced a $16 million gift to its Henry Ford Pancreatic Cancer Center, which was launched in 2018 by an initial $20 million gift from the same donor, who wishes to remain anonymous.
› Verified 5 days ago